HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Soluble beta-1,3/1,6-glucan

TERMINATED · PHASE1 · Burns

Slow patient recruitment

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.